high-risk soft tissue sarcoma
Showing 1 - 25 of >10,000
Soft Tissue Sarcoma Trial in Tucson, Baltimore, Pittsburgh (Combination Radiation, Immunotherapy, Surgery)
Recruiting
- Soft Tissue Sarcoma
- Combination Radiation, Immunotherapy, Surgery
-
Tucson, Arizona
- +2 more
Jan 30, 2022
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Surufatinib, Sintilimab, Radiotherapy)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Surufatinib
- +2 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Apr 20, 2023
High-Risk Localized Soft Tissue Sarcoma Trial in Shanghai (Pegylated Liposomal Doxorubicin, Doxorubicin, Anti-PD-1 mAb)
Recruiting
- High-Risk Localized Soft Tissue Sarcoma
- Pegylated Liposomal Doxorubicin
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Mar 15, 2023
Soft Tissue Sarcoma, High Risk of Recurrence, Anlotinib Trial in Shanghai (drug, radiation, procedure)
Recruiting
- Soft Tissue Sarcoma
- +3 more
- Anlotinib
- +2 more
-
Shanghai, Shanghai, ChinaRuijin Hospital Shanghai Jiao Tong University School of Medicine
Nov 1, 2022
Soft Tissue Sarcoma of the Extremity Trial in Worldwide (Pembrolizumab)
Recruiting
- Soft Tissue Sarcoma of the Extremity
-
Los Angeles, California
- +18 more
Dec 15, 2022
Non-metastatic Soft-tissue Sarcoma, Resectable Trial in France (Doxorubicin, Ifosfamide or dacarbazine, At the discretion of the
Recruiting
- Non-metastatic Soft-tissue Sarcoma
- Resectable
- Doxorubicin
- +2 more
-
Bordeaux, France
- +9 more
Jul 27, 2022
Pleomorphic Rhabdomyosarcoma, Stage IIB Adult Soft Tissue Sarcoma AJCC v7, Stage III Adult Soft Tissue Sarcoma AJCC v7 Trial in
Completed
- Pleomorphic Rhabdomyosarcoma
- +3 more
- Epirubicin Hydrochloride
- +5 more
-
Portland, OregonOHSU Knight Cancer Institute
Feb 23, 2022
Soft Tissue Sarcoma Trial in France (Standard of care + chemo, Standard of care)
Recruiting
- Soft Tissue Sarcoma
- Standard of care + chemotherapy
- Standard of care
-
Besançon, France
- +21 more
May 3, 2022
Soft Tissue Sarcoma Trial in GuangZhou (Camrelizumab in Combination With Neoadjuvant Chemotherapy)
Recruiting
- Soft Tissue Sarcoma
- Camrelizumab in Combination With Neoadjuvant Chemotherapy
-
GuangZhou, Guangdong, ChinaSun Yat-sen University cancer center
Oct 23, 2020
Soft-tissue Sarcoma, Predictive Cancer Model Trial in Netherlands (Care with the use of PERSARC, standard care)
Recruiting
- Soft-tissue Sarcoma
- Predictive Cancer Model
- Care with the use of PERSARC
- standard care
-
Nijmegen, Gelderland, Netherlands
- +6 more
Feb 14, 2023
Soft Tissue Sarcoma, Desmoid; Abdominal Trial in Oxford (High Intensity Focused Ultrasound Ablation, Tumour Biopsy and Venous
Recruiting
- Soft Tissue Sarcoma
- Desmoid; Abdominal
- High Intensity Focused Ultrasound Ablation
- Tumour Biopsy and Venous Blood Tests
-
Oxford, Oxfordshire, United KingdomChurchill Hospital
Jan 16, 2023
Soft Tissue Sarcoma Trial in Zhengzhou (Anrotinib HCl combined with adriamycin)
Recruiting
- Soft Tissue Sarcoma
- Anrotinib hydrochloride combined with adriamycin
-
Zhengzhou, Henan, ChinaHenan Cancer Hospital
Feb 27, 2023
Ewing's Family Tumors, Renal Tumors, Hepatoblastoma Trial in Minneapolis (drug, biological, radiation, procedure)
Recruiting
- Ewing's Family Tumors
- +11 more
- Ifosfamide
- +13 more
-
Minneapolis, MinnesotaMasonic Cancer Center, University of Minnesota
Apr 11, 2022
Soft Tissue Sarcoma Trial in Winston-Salem (drug, radiation, procedure, other)
Recruiting
- Soft Tissue Sarcoma
- Gemcitabine
- +4 more
-
Winston-Salem, North CarolinaWake Forest Baptist Comprehensive Cancer Center
Jan 26, 2023
Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults Trial in Italy, Spain (epirubicin 60
Active, not recruiting
- Localized High-risk Soft Tissue Sarcomas of the Extremities and Trunk Wall in Adults
- epirubicin 60 mg/m2/day (days 1, 2) and ifosfamide 3 g/m2/day (days 1, 2, 3)
- +5 more
-
Candiolo, TO, Italy
- +14 more
Nov 15, 2021
Sarcoma Trial in Chapel Hill (GRID therapy)
Not yet recruiting
- Sarcoma
- GRID therapy
-
Chapel Hill, North CarolinaUniversity of North Carolina at Chapel Hill, Department of Radia
Oct 5, 2023
Sarcoma, Soft Tissue Trial in Changsha (Cardunilizumab)
Active, not recruiting
- Sarcoma, Soft Tissue
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Oct 29, 2023
Soft Tissue Sarcoma Trial in Palo Alto (External Beam Radiotherapy)
Recruiting
- Soft Tissue Sarcoma
- External Beam Radiotherapy
-
Palo Alto, CaliforniaStanford University
Oct 11, 2023
Soft Tissue Sarcoma, Adult Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma Trial in Lyon (radiation, other, procedure)
Not yet recruiting
- Soft Tissue Sarcoma
- +2 more
- Neoadjuvant RT
- +3 more
-
Lyon, Rhône, FranceCentre Léon Bérard
Jan 12, 2023
Soft Tissue Sarcoma Adult, Angiosarcoma, Undifferentiated Pleomorphic Sarcoma Trial in Denmark, Norway, Sweden (Propranolol,
Recruiting
- Soft Tissue Sarcoma Adult
- +2 more
-
Aarhus, Denmark
- +3 more
Jul 23, 2023
Soft Tissue Sarcoma Trial in Guangzhou (Chiauranib)
Recruiting
- Soft Tissue Sarcoma
-
Guangzhou, Guangdong, ChinaSun Yat-Sen Univerisity
Sep 14, 2022
Advanced Soft-tissue Sarcoma Trial in Shenzhen (NY-ESO-1 TCR-T)
Recruiting
- Advanced Soft-tissue Sarcoma
- NY-ESO-1 TCR-T
-
Shenzhen, Guangdong, ChinaLi Yu
Nov 17, 2022